mafosfamide has been researched along with Necrosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bacher, N; Bauer, M; Becker, H; Heylmann, D; Kaina, B; Steinbrink, K; van Gool, S | 1 |
1 other study(ies) available for mafosfamide and Necrosis
| Article | Year |
|---|---|
Human CD4+CD25+ regulatory T cells are sensitive to low dose cyclophosphamide: implications for the immune response.
Topics: Apoptosis; Cyclophosphamide; Dose-Response Relationship, Drug; Humans; Immunosuppressive Agents; Interleukin-2 Receptor alpha Subunit; Necrosis; T-Lymphocytes, Regulatory | 2013 |